Transformed SCLCs usually retain original activating EGFR mutation, and the sharp increase in EGFR mutant AF at the moment of small cell transformation could be a consequence of the higher growth rate, the more aggressive behavior with increased tumor burden, and the enhanced DNA tumor shed observed in SCLC compared with NSCLC [12]. The gene discussed is EGFR; the disease is small cell lung carcinoma.